We can't forget about the Equity Purchase Agreemen
Post# of 36537
https://sec.report/Document/0001607062-20-000204/
"On July 14, 2020 (the “Closing Date”), NuGenerex Immuno-Oncology, Inc. (the “Company”) entered into an Equity Purchase Agreement (the “Purchase Agreement”) with an institutional accredited investor (the “Investor”) pursuant to which the Investor committed to purchase up to $50,000,000 (the “Maximum Commitment Amount”) of the Company’s common stock"